LEON O JR MOULDER
CIK 1228865 · See Remarks · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$172.22M
Companies
8
Total Filings
60
Lifetime Open-Market Net
$7.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZLAB | Director | 94,973 | $25.30 | $2.40M | $0 | 6 | 2026-06-22 |
| ZBIO | See Remarks | 520,083 | $31.98 | $16.63M | $6.91M | 13 | 2026-06-17 |
| DNTH | Director | 1,436,745 | $106.62 | $153.19M | $0 | 3 | 2024-05-28 |
| TREVENA INC (TRVN) Delisted | Director | 240 | $0.01 | $3 | $302.0K | 11 | 2023-06-20 |
| TESARO, Inc. (TSRO) Delisted | Chief Executive Officer | 0 | — | — | $401.5K | 11 | 2019-01-22 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | $0 | 1 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 9,098 | — | — | $183.9K | 7 | 2013-06-14 |
| MGI PHARMA INC (MOGN) Delisted | President & CEO | 17,500 | — | — | $0 | 6 | 2008-01-25 |
Recent Filings · Page 6 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-06-14 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | +305 | $0 | EDGAR |
| 2010-02-22 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-01 | — | Grant (A) | +50,000 | $0 | |
| 2008-01-30 | — | Mixed | −17,500 | -$1.99M | |
| 2008-01-25 | MGI PHARMA INC (MOGN) Delisted | U | −200,743 | -$8.23M | EDGAR |
| 2007-12-19 | MGI PHARMA INC (MOGN) Delisted | Tax (F) | −1,635 | -$38.5K | EDGAR |
| 2007-09-05 | MGI PHARMA INC (MOGN) Delisted | Tax (F) | −1,635 | -$38.5K | EDGAR |
| 2007-06-29 | MGI PHARMA INC (MOGN) Delisted | Gift (G) | −10,000 | $0 | EDGAR |
| 2007-05-11 | MGI PHARMA INC (MOGN) Delisted | Tax (F) | −2,616 | -$55.3K | EDGAR |
| 2007-02-22 | MGI PHARMA INC (MOGN) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 51–60 of 60
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.